Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Chylomicronemia Syndrome Is Most Often Multifactorial
Alan Chait, Robert H. Eckel
Annals of Internal Medicine (2019) Vol. 170, Iss. 9, pp. 626-626
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Antisense technology: an overview and prospectus
Stanley T. Crooke, Brenda F. Baker, Rosanne M. Crooke, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 6, pp. 427-453
Closed Access | Times Cited: 501
Clinical review on triglycerides
Ulrich Laufs, Klaus G. Parhofer, Henry N. Ginsberg, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 99-109c
Open Access | Times Cited: 421
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
Salim S. Virani, Pamela B. Morris, Anandita Agarwala, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 9, pp. 960-993
Open Access | Times Cited: 209
Management of hypertriglyceridemia
Vinaya Simha
BMJ (2020), pp. m3109-m3109
Open Access | Times Cited: 169
Genetics of Hypertriglyceridemia
Jacqueline S. Dron, Robert A. Hegele
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 161
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association
Carol F. Kirkpatrick, Geeta Sikand, Kristina Petersen, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 4, pp. 428-451
Open Access | Times Cited: 50
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Gerald F. Watts, Robert S. Rosenson, Robert A. Hegele, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 37
An overview of persistent chylomicronemia: much more than meets the eye
Miriam Larouche, Gerald F. Watts, Christie M. Ballantyne, et al.
Current Opinion in Endocrinology Diabetes and Obesity (2025)
Closed Access | Times Cited: 2
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
Emily Brown, Amy C. Sturm, Marina Cuchel, et al.
Journal of clinical lipidology (2020) Vol. 14, Iss. 4, pp. 398-413
Open Access | Times Cited: 107
A Comprehensive Update on the Chylomicronemia Syndrome
Ronald Goldberg, Alan Chait
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 97
Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases
Anna Kłoska, Magdalena Węsierska, Marcelina Malinowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6113-6113
Open Access | Times Cited: 73
RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
Daniel Gaudet, Peter Clifton, David Sullivan, et al.
NEJM Evidence (2023) Vol. 2, Iss. 12
Closed Access | Times Cited: 33
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA
Eliot A. Brinton, Robert H. Eckel, Daniel Gaudet, et al.
Atherosclerosis (2025), pp. 119114-119114
Closed Access | Times Cited: 1
<p>Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy</p>
Oluwayemisi Esan, Anthony S. Wierzbicki
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 2623-2636
Open Access | Times Cited: 68
Hypertriglyceridemia
Alan Chait
Endocrinology and Metabolism Clinics of North America (2022) Vol. 51, Iss. 3, pp. 539-555
Closed Access | Times Cited: 31
Safety and efficacy of therapies for chylomicronemia
Isabel Shamsudeen, Robert A. Hegele
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 4, pp. 395-405
Open Access | Times Cited: 29
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial
Joseph L. Witztum, Daniel Gaudet, Marcello Arca, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 3, pp. 342-355
Closed Access | Times Cited: 22
Lipid-lowering in diabetes: An update
Alan Chait, Robert H. Eckel, Michal Vráblík, et al.
Atherosclerosis (2023) Vol. 394, pp. 117313-117313
Open Access | Times Cited: 20
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Daniel Soffer, Nicholas Marston, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e647-e663
Closed Access | Times Cited: 8
Comparison of patients with familial chylomicronemia syndrome and multifactorial chylomicronemia syndrome
Catherine M. Spagnuolo, Jian Wang, Adam D. McIntyre, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 7
Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia
Simon‐Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Atherosclerosis (2024) Vol. 392, pp. 117489-117489
Closed Access | Times Cited: 6
The polygenic nature of mild-to-moderate hypertriglyceridemia
Jacqueline S. Dron, Jian Wang, Adam D. McIntyre, et al.
Journal of clinical lipidology (2020) Vol. 14, Iss. 1, pp. 28-34.e2
Closed Access | Times Cited: 44
Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia
Genovefa Kolovou, Vana Kolovou, Niki Katsiki
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 982-982
Open Access | Times Cited: 23
Elevated plasma triglyceride concentration and risk of adverse clinical outcomes in 1.5 million people: a CALIBER linked electronic health record study
Riyaz Patel, Laura Pasea, Handrean Soran, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Chylomicronemia from GPIHBP1 autoantibodies
Kazuya Miyashita, Jens Lutz, Lisa C. Hudgins, et al.
Journal of Lipid Research (2020) Vol. 61, Iss. 11, pp. 1365-1376
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top